FOI 25-0097 LD – Documents For PBS Listing Change

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

This FOI release contains a PBS submission from the National LGBTI Health Alliance requesting changes to testosterone prescribing restrictions to improve access for transgender, intersex, and gender-diverse patients. The submission sought to restore GP prescribing authority for testosterone in androgen deficiency without mandatory specialist consultation, except where medical need exceeds GP scope, and requested specialist consultation only with endocrinologists holding specific expertise in the relevant population. The submission also requested removal of the "male" requirement from PBS restrictions and modifications to informed consent provisions for intersex patients receiving puberty induction or micropenis treatment. The document includes TGA approval status for testosterone in various forms for androgen replacement and hypogonadism in males, with the submission evaluated at the July 2015 PBAC meeting.